Search - tctmd.com

Displaying 61 - 80 of 103

Sort: Relevancy | Date

News Industry News

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

February 07, 2017

News Opinion Fellow Talk

Continuity Clinics: Indispensable to Medicine but Extraneous for Interventional Cardiology Fellows

Ankur Kalra

September 24, 2016

News Industry News

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

September 12, 2016

News Daily News

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Todd Neale

March 06, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Daily News

心脏科医生在报告患者心绞痛发作频率方面存在“巨大”差异

Todd Neale

March 03, 2016

News Daily News

‘Striking’ Differences in How Cardiologists, Patients Report Angina Frequency

Todd Neale

March 03, 2016

News Daily News

“Sorprendentes” Diferencias en Cómo Cardiólogos y Pacientes Informan de la Frecuencia de las Anginas

Todd Neale

March 03, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Features

Trials Prompt Interventionalists to Reconsider Complete Revascularization for STEMI

Kim Dalton

March 09, 2015

$Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina$

Presentation

Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina

Presenter: S. Verheye

February 03, 2015

News Daily News

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Todd Neale

February 03, 2015

News Daily News

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Yael L. Maxwell

November 06, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Daily News

2014 Guideline for NSTE-ACS Management Has New Name, Focus

September 30, 2014

News Industry News

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

September 15, 2014

News Daily News

绞痛而不是缺血能够预测CAD结果

Todd Neale

August 20, 2014

Advertisement

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

Continuity Clinics: Indispensable to Medicine but Extraneous for Interventional Cardiology Fellows

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

心脏科医生在报告患者心绞痛发作频率方面存在“巨大”差异

‘Striking’ Differences in How Cardiologists, Patients Report Angina Frequency

“Sorprendentes” Diferencias en Cómo Cardiólogos y Pacientes Informan de la Frecuencia de las Anginas

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

Trials Prompt Interventionalists to Reconsider Complete Revascularization for STEMI

Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina

Narrowing Coronary Sinus May Provide Relief From Refractory Angina

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

2014 Guideline for NSTE-ACS Management Has New Name, Focus

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

绞痛而不是缺血能够预测CAD结果

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content